High expression of the non-receptor tyrosine kinase FER is an independent prognostic factor that correlates with poor survival in breast cancer patients. To investigate whether the kinase activity is essential for FER oncogenic properties, we developed an ATP analogue-sensitive knock-in allele (FERASKI). Specific FER kinase inhibition in MDA-MB-231 cells reduces migration, invasion, and metastasis in a mouse model of breast cancer. Using the FERASKI system, we identify SKI family transcriptional corepressor 1 (SKOR1) as a direct FER kinase substrate. SKOR1 loss phenocopies FER inhibition, leading to impaired proliferation, migration and invasion, and inhibition of breast cancer growth and metastasis formation in mice. We show that the candidate FER phosphorylation residue, SKOR1-Y234, is essential for FER-dependent tumor progression features. Finally, our work suggests that the SKOR1-Y234 residue promotes Smad2/3 signaling through SKOR1 binding to Smad3 attenuation. Our study thus identifies SKOR1 as a mediator of FER-dependent progression of high-risk breast cancers.
SKOR1 mediates FER kinase-dependent invasive growth of breast cancer cells
- Award Group:
- Funder(s): KWF Kankerbestrijding
- Award Id(s): UU2014-7201
- Funder(s):
- Award Group:
- Funder(s): HORIZON EUROPE European Innovation Council
- Award Id(s): 731957
- Funder(s):
- Award Group:
- Funder(s): Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Award Id(s): NWO-TOP 02007
- Funder(s):
Currently Viewing Accepted Manuscript - Newer Version Available
- Split-screen
- Views Icon Views
- Open the PDF for in another window
-
Article Versions Icon
Versions
- Version of Record 06 February 2023
- Accepted Manuscript 09 January 2023
- Share Icon Share
-
Tools Icon
Tools
- Search Site
Lilian M. Sluimer, Esme Bullock, Max A. K. Rätze, Lotte Enserink, Celine Overbeeke, Marten Hornsveld, Valerie G. Brunton, Patrick W. B. Derksen, Sandra Tavares; SKOR1 mediates FER kinase-dependent invasive growth of breast cancer cells. J Cell Sci 2023; jcs.260243. doi: https://doi.org/10.1242/jcs.260243
Download citation file:
Advertisement
Imaging Cell Architecture and Dynamics
We are still welcoming submissions for our upcoming Special Issue: Imaging Cell Architecture and Dynamics. This issue will be coordinated by two Guest Editors: Lucy Collinson (The Francis Crick Institute, UK) and Guillaume Jacquemet (University of Turku, Finland). Extended submission deadline: 29 March 2024.
Journal of Cell Science - more than just a journal
People who know JCS well will know that we're more than just a journal and that our community – the cell biology community – really is at the heart of everything we do. Read the full Editorial by Editor-in-Chief Michael Way and Executive Editor Seema Grewal.
2024 Journal Meeting 'Diversity and Evolution in Cell Biology'
Registration is open for our 2024 Journal Meeting Diversity and Evolution in Cell Biology, which aims to bring together evolutionary biologists and cell biologists investigating diverse aspects of cellular physiology. Submit your abstract by 5 April. Final registration deadline: 3 May 2024.
Workshop: Roles of Lipids in Nuclear Homeostasis and Genome Stability
Early-career researchers interested in the roles of nuclear lipids, apply now for one of the ten funded places at this Workshop, which will take place 14-17 October 2024. Application deadline: 19 April.
Reasons to submit to Journal of Cell Science
There are many benefits to publishing in Journal of Cell Science - read more about why you should choose JCS or visit our submission page now.